BS Medicine Episode #579: Oral Calcitonin Gene-related Peptide Antagonists: A painfully long name for the acute treatment of migraines
Release Date: 08/20/2024
In the Clinic Episode #31: Urinary tract infection
CFPCLearn
In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Sissy Hayes, a 38 year old patient who thinks she has a urinary tract infection.
info_outline
In the Clinic Episode #30: Osteoporosis
CFPCLearn
In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Dixie Brittle, an elderly patient who is worried about fractures.
info_outline
BS Medicine Episode #590: 3 publications with possibly surprising results
CFPCLearn
In episode 590, Mike and James talk in a PREMIUM way about a new trial that looked at the question, does depression screening provide any benefit in primary care? We also go over a case-finding publication on screening for asthma/COPD. At the end we look at, does implementing guideline care improve outcomes for CKD?
info_outline
BS Medicine Episode #589: Vitamin D and Fracture Prevention: Not what it’s cracked up to be?
CFPCLearn
In episode 589, Mike and James invite Jennifer Young back to the podcast again to talk about a topic that Mike absolutely loves – Vitamin D for everyone. Tune in to hear about all the latest, and the older, evidence. Do you agree we should remove the question mark from the podcast title? Show notes 1) Tools for Practice
info_outline
BS Medicine Episode #588: Strategies for initiating insulin in type 2 diabetes
CFPCLearn
In episode 588, Mike and James invite Émélie Braschi back to the podcast to discuss another tricky area – insulin in type 2 diabetes and how to use it. Do we need to give it once a day, twice a day or maybe no times a day? Tune in to hear about all the evidence. Show notes 1) Tools for Practice
info_outline
In the Clinic Episode #29: Stomach problems
CFPCLearn
In this episode of In the Clinic, Mike and Jess are joined by Mike Kolber, family physician from Peace River, Alberta. The team discusses Michelle Reblok - a 25 year old patient who presents with stomach problems - and works through the differential diagnosis. To claim Mainpro+ credits, click here:
info_outline
In the Clinic Episode #28: Heavy menstrual bleeding
CFPCLearn
Mike, Jess and Jennifer follow up with Farrah Lo, a 27 year old patient, who was diagnosed with iron deficiency anemia in an earlier podcast. Today, the team discusses the management of heavy menstrual bleeding. Did you miss Farrah's original visit? Tune into episode #13: To claim your Mainpro+ credit, click here:
info_outline
BS Medicine Episode #587: Mission Slimpossible – Oral GLP-1 agonists for weight loss
CFPCLearn
In episode 587, Mike and James invite Adrienne Lindblad back to the podcast to go over all the evidence we have for the oral GLP-1 weight loss medications. You know you are going to get lots of questions about these medications so tune in to find out all the numbers around the benefit and potential harms – and cost. Show notes 1) Tools for Practice
info_outline
BS Medicine Episode #586: It’s time to challenge penicillin allergy labels
CFPCLearn
In episode 585, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it or not there are a couple of RCTs looking at this issue. These two trials compared oral challenge alone to skin testing followed (if negative) by oral challenge. The results may allow you to change your practice in a good way. Tune in and find out why. Show notes Tools for Practice
info_outline
BS Medicine Episode #585: PREMIUM – Beta-blockers after an MI and respiratory specialists for COPD
CFPCLearn
In episode 585, Mike and James finally get back to being PREMIUM. We review the REDUCE-AMI trial which tried to answer the question – do you need to use a beta-blocker after an MI if there is preserved ejection fraction? We also review a COPD trial that shows integrating respiratory specialists in primary care improves guideline adherence. However, the interesting finding is what happens to the quality-of-life change and hospitalizations. The results of both of these trials may surprise you. Show notes 1) REDUCE-AMI- Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction ...
info_outlineIn episode 579, Mike and James invite Nicholas Dugré back to the podcast to talk about the evidence around the benefits and harms of a new class of medications for the acute treatment of episodic migraines. Ubrogepant is an oral calcitonin gene-related peptide antagonist. In this case, amazing as it may sound, there are triple the number of systematic reviews than there are RCTs. Nonetheless, we go over all the evidence and at the end of the podcast you’ll know what the world knows about these agents.
Show notes
Tools for Practice